Dr. Mitchener joined Alpha-9 as CBO in December 2023, bringing over 20 years of pharmaceutical experience with a focus on Commercial, Business Development, Strategy and General Management. Dr. Mitchener’s career spans both global and US focused roles in both the Big Pharma and Biotech setting. Previous roles include Head of Strategy, Partnering, and Operations for the US Division of Novartis Oncology, Head of Novartis Oncology Franchise for Australia/New Zealand, and multiple CBO roles encompassing successful capital raises and in-licensing/out-licensing initiatives ranging from discovery to commercial stage deals. Dr. Mitchener received his PharmD from the University of North Carolina at Chapel Hill.

• 

  Chief Business Officer (CBO) in Alpha-9 Oncology

  Harnessing the Power of Radiopharmaceuticals